EQICX
Price
$12.92
Change
+$0.11 (+0.86%)
Updated
Jun 25 closing price
Net Assets
363.97M
RNWHX
Price
$86.55
Change
+$0.06 (+0.07%)
Updated
Jun 25 closing price
Net Assets
68.95B
Interact to see
Advertisement

EQICX vs RNWHX

Header iconEQICX vs RNWHX Comparison
Open Charts EQICX vs RNWHXBanner chart's image
Allspring Emerging Markets Eq Advtg C
Price$12.92
Change+$0.11 (+0.86%)
VolumeN/A
Net Assets363.97M
American Funds New World R5E
Price$86.55
Change+$0.06 (+0.07%)
VolumeN/A
Net Assets68.95B
EQICX vs RNWHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EQICX vs. RNWHX commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQICX is a Buy and RNWHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 68.9B vs. EQICX (364M). RNWHX pays higher dividends than EQICX: RNWHX (1.04) vs EQICX (0.98). EQICX was incepted earlier than RNWHX: EQICX (13 years) vs RNWHX (10 years). EQICX (2.36) is less costly to investors than RNWHX (0.72). EQICX is a more actively managed with annual turnover of: 81.00 vs. RNWHX (37.00). RNWHX has a lower initial minimum investment than EQICX: RNWHX (250) vs EQICX (1000). RNWHX annual gain was more profitable for investors over the last year : 9.82 vs. EQICX (7.63). EQICX return over 5 years is better than : 41.17 vs. RNWHX (33.72).
EQICXRNWHXEQICX / RNWHX
Total Expense Ratio2.300.72319%
Annual Report Gross Expense Ratio2.360.72328%
Fund Existence13 years10 years-
Gain YTD9.13113.85266%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets364M68.9B1%
Annual Yield % from dividends0.981.0494%
Returns for 1 year7.639.8278%
Returns for 3 years24.4533.8272%
Returns for 5 years41.1733.72122%
Returns for 10 years25.12N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HSII43.60-0.28
-0.64%
Heidrick & Struggles International
FATE1.16-0.01
-0.85%
Fate Therapeutics
DXC14.98-0.19
-1.25%
DXC Technology Company
TAP47.24-0.98
-2.03%
Molson Coors Beverage Company
INTS0.29-0.01
-2.07%
Intensity Therapeutics